Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trial.
Li-Nong JiEun Seok KangXiaoLin DongLing LiGuoYue YuanShuhua ShangElisabeth Niemoellernull nullPublished in: Diabetes, obesity & metabolism (2019)
Glycaemic control of Gla-300 is non-inferior to Gla-100 with a similar or lower incidence and proportion of hypoglycaemia in people with type 2 diabetes in Asia Pacific, reinforcing the results in the global EDITION programme.